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A B S T R A C T
Uncaria tomentosa (Willd.) DC. (Rubiacee), also known as uña de gato, is a plant that grows wild in the upper
Amazon region of Peru and has been widely used in folk medicine to treat several health conditions including
cancer. We have produced an aqueous extract from Uncaria tomentosa (UT-ex) and analyzed its eﬀects on
squamous carcinoma cells and immortalized HaCaT keratinocytes. Squamous cell carcinoma (SCC) is an un-
controlled growth of abnormal cells arising in the skin's squamous layer of epidermis. When detected at an early
stage, SCCs are almost curable, however, if left untreated, they can penetrate the underlying tissue and become
disﬁguring. We have evaluated cell proliferation, apoptosis and the level of reactive oxygen species following
UT-ex treatment. UT-ex aﬀected cell cycle progression and reduced cell viability in a dose and time-dependent
manner. From a mechanistic point of view, this delay in cell growth coincided with the increase of reactive
oxygen species (ROS). Furthermore, PARP1 cleavage was associated to the reduction of Y-box binding protein 1
(YB-1) 36 kDa, a nuclear prosurvival factor involved in DNA damage repair. These data indicate that UT-ex-
induced cell death can be ascribed, at least in part, to its ability both to induce oxidative DNA damage and
antagonize the mechanism of DNA repair relying upon YB-1 activity. They also show that non metastatic SCCs
are more susceptible to UT-ex treatment than untransformed keratinocytes supporting the use of UT-ex for the
treatment of precancerous and early forms of squamous cell carcinomas. Preliminary chemical investigation of
UT-ex revealed the presence of hydrophilic low-medium molecular weight metabolites with anticancer potential
towards squamous carcinoma cells.
1. Introduction
Squamous cell carcinoma (SCC) is an uncontrolled growth of ab-
normal cells arising in the squamous cells, which compose most of the
skin's upper layers (Sapijaszko et al., 2015). SCCs may occur on any part
of the body, including the mucous membranes and genitals, but are
most common in areas frequently exposed to the sun, such as the neck,
face, balding scalp, arms and legs. Squamous cell carcinomas detected
at an early stage are almost always curable. However, left untreated,
they eventually penetrate the underlying tissues and can become dis-
ﬁguring. A small percentage may even metastasize to local lymph
nodes, distant tissues, and organs and can become fatal. Actinic kera-
toses (AKs) are considered the earliest form of SCC and may be the ﬁrst
sign of squamous cell carcinoma (Boukamp, 2005); indeed, 40–60% of
squamous cell carcinomas begin as untreated AKs.
Though considerable progress has been made in developing eﬀec-
tive skin cancer treatments, surgery and radiation are still predominant
and it would be beneﬁcial to ﬁnd new topical treatments for pre-
cancerous skin lesions to prevent their progression.
Nowadays, there is an increased demand for alternative concepts or
approaches to cancer treatment. Compelling evidence from epidemio-
logical and experimental studies highlight the importance of com-
pounds derived from plants, “phytochemicals”, for inhibiting the de-
velopment and spread of tumors in pre-clinical studies.
Uncaria tomentosa (Willd.) DC., from the Rubiaceae family, is a
thorny liana that grows wild in the upper Amazon region of Peru and
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neighboring countries. In Peru, Uncaria tomentosa, also known as uña de
gato, is believed to have anti-inﬂammatory and anti-tumoral properties
(Heitzman et al., 2005; Garcia Prado et al., 2007). The boiled extract of
Uncaria tomentosa root/bark has been used over the centuries by the
indigenous civilization of the Amazonian rain forest for the treatment of
fever, rheumatism, arthritis, gastrointestinal disorders, cirrhosis, neu-
rodegenerative diseases, microbial infections, cancer, skin impurities
and inﬂammation (Keplinger et al., 1998; Ccahuana-Vasquez et al.,
2007).
Many active compounds have been isolated from Uncaria tomentosa
including antioxidants such as tannin, catechins, and procyanidins,
sterols, triterpenes, ﬂavonoids, carboxyl alkyl esters, indol and oxindol
alkaloids (Heitzman et al., 2005; Wagner et al., 1985a). In particular,
alkaloids, the major active components of Uncaria species were ex-
tensively studied for their potential use as anticancer agents and found
to be eﬀective against the proliferation of breast and bladder tumor
lineages (Riva et al., 2001; Kaiser et al., 2013). From a mechanistic
point of view, Uncaria tomentosa was found to aﬀect tumor growth by
inhibiting the Wnt or NF-kB/TNFα signaling pathways (Akesson et al.,
2003; Gurrola-Diaz et al., 2011). Moreover, Uncaria tomentosa aqueous
extract was reported to enhance DNA repair in human skin organ cul-
tures irradiated with UV-B (Mammone et al., 2006) and to abate actinic
keratoses and early squamous cell cancer in hairless mice exposed to
UV-A radiation thereby suggesting its possible application as a product
for skin cancer protection (Mentor et al., 2015).
The aim of the present study was to analyze, the biological eﬀects of
Uncaria tomentosa extract on human immortalized keratinocytes and
squamous carcinoma cells in order to provide molecular evidence
supporting its therapeutic use against this type of cancer.
2. Materials and methods
2.1. Cell culture and reagents
HaCaT, spontaneously immortalized keratinocytes from adult skin,
were purchased from Service Cell Line (CLS, Germany) and cultured as
described (Amoresano et al., 2010); A431, human epidermoid carci-
noma cells were from American Type Culture Collection (ATCC, Man-
assas, VA). Head and neck cancer cell lines SCC011, SCC013 and SC-
C022 were originally derived from tumors in patients aﬀected by
squamous cell carcinoma of the upper aerodigestive tract (Resto et al.,
2008). HaCaT and A431 cell lines were cultured in Dulbecco's Modiﬁed
Eagle's Medium (DMEM, Sigma Chemical Co, St. Louis, MO, USA),
while all SCC lines were cultured in Roswell Park Memorial Institute
medium (RPMI 1640 Sigma Chemical Co, St. Louis, MO, USA). All cell
line cultures were supplemented with 10% fetal bovine serum (FBS,
Hyclone Laboratories, Inc., Logan, UT, USA), 1% L-glutamine, and 1%
penicillin-streptomycin (ICN Biomedicals, Inc., Aurora, OH, USA) at
37 °C in humidiﬁed atmosphere of 5% CO2.
2.2. Bright-ﬁeld microscopy
HaCaT, A431, SCC011, SCC013 and SCC022 cells were plated at a
density of 2.5 × 105 per well and treated with the indicated doses of
Uncaria Tomentosa. After 24 h of treatment, images were acquired in
phase-contrast at Nikon Eclipse TE-2000U.
2.3. Antibodies
The primary antibodies GAPDH (6C5), actin (I-19) and actinin (H-2)
were purchased from Santa Cruz Biotechnology, Inc. Santa Cruz, CA,
USA). Primary antibodies YB-1 (ab12148), hnRNPA1 (ab177152) were
from Abcam (Cambridge, UK). PARP1, p21-WAF (12D1), Bax (D2E11)
and H2AX antibodies were from Cell Signaling (Beverly, MA). Anti-
Ubiquitin antibodies were purchased from DAKO (Glostrup, Denmark).
2.4. Extract preparation
The water extract of Uncaria tomentosa bark (UT-ex) used for the
experiments was prepared as follows: 15 g of dried bark were shredded
and boiled for 30 min in 500 ml of bi-distilled H2O, then cooled at room
temperature (RT) and ﬁltered through sterile gauze. The concentration
(w/v) was estimated by the ratio between the weight of the bark, ex-
pressed in grams, and the ﬁnal volume obtained at the end of the
preparation:
=g g15 /400ml [00.0375 /ml]
UT-ex contains 1.28 mg/ml of proteins as determined by Bradford
assay, 3.08 mg/ml phenols and 4.05 mg/ml carboidrates (2.08 pentoses
and 1.97 hexoses).
The water extract was ﬁltered through a 0.20 µm ﬁlter before being
applied to the cells. An aliquot was lyophilized (SAVANT, SC110 Speed
Vac Plus A) and resuspended in the initial volume of sterile H2O in
order to check for loss of properties during the sublimation process
(ReUT-ex).
2.5. Cell viability assay
The eﬀect of Uncaria tomentosa on cell viability was evaluated by
measuring the reduction of 3-(4,5-dimethylthiazol-2) 2,5-diphenylte-
trazolium bromide (MTT) to formazan by mitochondrial dehy-
drogenase. Brieﬂy, 9×103 cells were seeded on 96-well plates and ex-
posed to increasing concentrations of UT-ex (from 0.3 to 10 mg/ml) for
24, 48 and 72 h. MTT/PBS solution (0.5 mg/ml) was then added to the
wells and incubated for 3 h at 37 °C in a humidiﬁed atmosphere. The
reaction was stopped by removal of the supernatant followed by dis-
solving the formazan product in acidic isopropanol. Optical density was
measured with an ELISA reader (Bio-Rad) using a 570 nm ﬁlter. Under
these conditions, undissolved formazan crystals were not observed. Cell
viability was assessed comparing optical density of the treated samples
compared to the control group.
2.6. Cell growth proﬁle
HaCaT, A431 and SCC022 cells were plated at a density of 2.5 ×
105 per well in a Corning 6 well plate and the counts were performed in
a Neubauer chamber by Trypan Blue dye exclusion. Brieﬂy, 20 μL cell
suspension was diluted 1:1 with 0.4% solution of trypan blue in phos-
phate saline buﬀer pH 7.2. Cell counting was carried out at 24-hr in-
tervals for 3 days.
2.7. Cell cycle analysis
Cells were seeded at 3 × 105 in 35 mm dishes and treated with UT-
ex at 0.3 and 1.5 mg/ml for 24 h. Cells were then trypsinized and wa-
shed by centrifugation (1200 rpm, 4 min, 4 °C) in Phosphate Buﬀered
Saline (PBS 1x). The cell pellet was resuspended in methanol, incubated
in ice for 20 min and centrifuged at 1200 rpm, 5 min, 4 °C. After a wash
in PBS, the cell pellet was incubated in PBS 1x, containing RNase
100 µg/ml for 20 min at RT. Propidium iodide was then added at a
concentration of 50 µg/ml for 30 min at 4 °C. Cell cycle analysis was
performed on the BD Accury™ C6 ﬂow cytometer (BD Biosciences). Cell
debris and aggregates were excluded from the analysis.
2.8. Western blot and immunoprecipitation analyses
Immunoblots (IB) and immunoprecipitations (Co-IP) were per-
formed as previously described (Calabrò et al., 2004; Di Costanzo et al.,
2011). Uncaria tomentosa treated and untreated cells were harvested in
lysis buﬀer (50 mM Tris-HCl pH 7.5, 5 mM EDTA, 150 mM NaCl, 1%
NP-40, 1 mM phenylmethylsulfonyl ﬂuoride, 0.5% sodium deox-
ycholate, and protease inhibitors) as previously described (Lo Iacono
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et al., 2006). Total cell lysates were incubated on ice for 40 min and
clariﬁed by centrifugation at 13,200 rpm for 15 min at 4 °C. The
amount of protein in the samples was determined by the Bio-Rad pro-
tein assay (Bio-Rad, Milan, Italy). After the addition of Laemmli buﬀer
(Sigma Chemical Co, St. Louis, MO, USA) the samples were boiled at
100 °C for 5 min and resolved by SDS-polyacrylamide gel electrophor-
esis (SDS-PAGE). The proteins were then transferred to a poly-
vinylidene diﬂuoride membrane (PDVF, Millipore) using a Mini trans-
blot apparatus (Bio-Rad, Milan, Italy) according to manufacturer's in-
structions. The PVDF membrane was blocked in 5% w/v milk buﬀer
(5% w/v non-fat dried milk, 50 mM Tris, 200 mM NaCl, 0.2% Tween
20) and incubated with primary antibodies diluted in 5% w/v milk or
bovine serum albumin (BSA) buﬀer for 2 h at RT or overnight at 4 °C.
The blots, washed three times with TTBS (Tris-buﬀered saline, 0.1%
Tween), were incubated for 1 h at RT with HRP-conjugated secondary
antibodies (Santa-Cruz biotechnology). The proteins were visualized by
an enhanced chemiluminescence method (ECL, GE-Healthcare) and
analyzed by Quantity One W software of ChemiDoc TM XRS system
(Bio-Rad, Milan, Italy). For IP experiments, extracts were pre-cleared
with 30 μL of protein A-agarose (50% slurry; Roche, Manheim, Ger-
many), and incubated overnight at 4 °C with anti-YB-1 (3 μg) or α-
rabbit IgG (3 μg). Whole extracts were separated by SDS-PAGE and
subjected to immunoblot, as previously described.
2.9. Reactive oxygen species (ROS) generation assay
Intracellular ROS generation was measured by ﬂow cytometry using
2′−7′ dichloroﬂuorescein diacetate (DCFDA), a non-ﬂuorescent com-
pound permeable to the cell membrane, which can be oxidized by ROS,
giving a ﬂuorescent compound. In brief, 3 × 105 cells were treated with
diﬀerent concentrations of Uncaria tomentosa (0.3 and 3 mg/ml), the
medium was removed after 24 h and cells were washed with PBS. Fresh
medium with DCFDA (1 mM) was added for 30 min, then DCFDA was
removed by washing in PBS and the cells were harvested. The mea-
surement of ROS was obtained using ﬂow cytometry Accuri C6 (BD-
biosciences, US) and for each sample at least 10, 000 events were
evaluated. The ﬂuorescence emitted from the cells treated with DCFDA,
compared to the untreated cells, was performed using the FL1-A
(530–533 nm) channel. The data obtained as mean ﬂuorescence in-
tensities were analyzed and converted into percentages of ROS by BD
Accuri C6 Software.
2.10. Genomic DNA extraction
Uncaria tomentosa treated and untreated cells were harvested in lysis
buﬀer (10 mM Tris pH 8.0, 50 mM NaCl, 20 μg/ml di Proteasi K, 20 μg/
ml di RNasi) with 1% SDS. Samples were incubated 2 h at 55 °C and
then treated with 1.5 M of NaCl. A 1:1 vol of chloroform was added and
samples were incubated for 1 h on rotation at room temperature.
Samples were centrifuged at 13,200 rpm for 3 min, then 0.7 vol (com-
pared to volume of lysis buﬀer) of isopropanol was added to super-
natants.
Samples were centrifuged for 3 min at 13,200 rpm, the white pellet
was resuspended in TE solution. 20 microliters of each sample were
loaded in 1.2% agarose gel in TAE buﬀer. Images were acquired after
trans-UV irradiation and analyzed by Quantity One W software of
ChemiDoc TM XRS system (Bio-Rad, Milan, Italy).
2.11. Comet assay
The glass slides were coated with 50 μL of normal-melting-point
agarose (0.7%). Then, 200 μL of 1% agarose were applied and allowed
to solidify at 4 °C. Then, 50 μL of cell/agarose mixture, 25 μL of 0.7%
agarose plus 25 μL of cell suspension (105 cells), was applied as a third
layer. After 20 min in ice, 200 μL of 0.7% agarose was applied as a
cover layer of the microgel.
The slides were immersed in cold fresh lysis solution (2.5 M NaCl,
100 mM EDTA, 10 mM Tris) for 1.5 h at 4 °C and then placed for 20 min
in electrophoresis buﬀer (300 mM NaOH, 1 mM EDTA, pH 13). The
electrophoresis was performed at 25 V at room temperature for 30 min.
The slides were then rinsed twice with the neutralization buﬀer (0.4 M
Tris, pH 7.5) and stained with DAPI.
Images were acquired with Nikon Eclipse TE-2000U ﬂuorescence
microscope. Cells (100) were counted and those showing the comet
were expressed as percentage of the total.
Fig. 1. (A) Percentage of viability of HaCaT, SCC013, SCC011, SCC022 and A431 cell lines after 48 h of incubation with the indicated doses of UT-ex (mg/ml). Cell viability was measured
by the chromogenic MTT assay and is expressed as the percentage of viable cells compared to cells in the absence of the plant extract (mean± S.D. n = 6 technical replicates). ANOVA *
p<0.05, ** p< 0.005. (B) Bright-ﬁeld microscopy of representative images of A431, SCC022, SCC011, SCC013 and HaCaT cells after 24 h of incubation with UT-ex at increasing
concentrations from 0 to 10 mg/ml (0, 0.3, 3.0 and 10 mg/ml).
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2.12. Statistical analysis
Statistical signiﬁcance of diﬀerence in measured variables between
control and treated groups was determined by t-test or one-way
ANOVA. Diﬀerence was considered signiﬁcant at P<0.05 (*) and
P<0.005 (**).
2.13. General chemical procedures
Analytical and preparative TLC were performed on silica gel
(Kieselgel 60, F254, 0.20 and 0.5 mm respectively) and on reversed
phase (Kieselgel 60 RP-18, F254, 0.20 mm) plates (Merck, Darmstadt,
Germany). The spots were visualized by exposure to UV radiation
(254), or by spraying ﬁrst with 10% H2SO4 in MeOH and then with 5%
phosphomolybdic acid in EtOH, followed by heating at 110 °C for
10 min.
The HPLC system (HITACHI) consisted of a pump (5160) and a
spectrophotometric detector (5410). The HPLC separation were per-
formed using a Phenomenex LUNA (C18 (2) 5 u 150 × 4.6 mm). The
mobile phase used to elute the samples was MeOH:H2O, 0.1% TFA at a
ﬂow rate of 0.4 ml/min. The analysis was performed using a linear
gradient starting from 30% of MeOH increased linearly to 50% MeOH
in 10 min and holded this conditions for 25 min. The initial conditions
were restored according to a linear gradient over 5 min and the column
was re-equilibrated under these conditions for 10 min before the next
run. Detection was performed at 250 nm. Samples were injected using a
20-μL loop and monitored for 30 min.
1H NMR spectra were recorded at 400 or 500 MHz in CDCl3 on
Bruker (Karlsruhe, Germany) and Varian (Palo Alto, CA, USA). The
same solvent was used as internal standard.
LC-TOF analysis were performed using the LC/MS TOF system
(AGILENT 6230B, HPLC 1260 Inﬁnity), using the same HPLC condi-
tions.
Spectra/Por Dyalisis Membrane (cut-oﬀ 3500 Da) were purchased
from Sigma (Milan, Italy) and the dialyses carried out for two days
against a large volume of distilled water.
3. Results
3.1. UT-ex cytotoxicity in squamous carcinoma cells
Human immortalized HaCaT keratinocytes and keratinocyte-de-
rived squamous carcinoma cells (SCC013, SCC011, SCC022 and A431)
were treated for 48 h with increasing doses of UT-ex, from 0.5 to
10 mg/ml, and cell viability was analyzed by MTT assay. The yellow
tetrazolium salt 3-(4, 5-dimethylthiazol-2-yl)−2, 5-diphenylte-
trazolium bromide (MTT) is widely used to determine cell viability in
cell proliferation and cytotoxic assays. MTT is reduced by metabolically
Fig. 2. (A–E) Percentage of viability of A431, HaCaT, SCC022, SCC011 and SCC013 cells after 24, 48 and 72 h of incubation with increasing doses of UT-ex (0.3, 0.5, 1, 1.5, 2, 2.5, 3.0 and
10 mg/ml). Cell viability was measured by the chromogenic MTT assay and is expressed as the percentage of viable cells compared to cells in the absence of the plant extract (mean± S.D.
n = 6 technical replicates). ANOVA * p<0.05, ** p<0.005.
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active cells to form an insoluble purple formazan product that is
quantiﬁable by spectrophotometry. At 0.5 mg/ml of UT-ex, im-
mortalized HaCaT, highly metastatic SCC022, and non-metastatic
SCC013 and SCC011 cells were more viable than control cells (ranging
from 1.1 to 1.5 folds) (Fig. 1A). Vulvar epidermoid A431 cells remained
almost unaﬀected by treatment with 0.5 mg/ml of UT-ex (Fig. 1A). At
higher concentrations, UT-ex was clearly cytotoxic and exhibited a
dose-dependent eﬀects in all tested cell lines (Fig. 1A). Compared to
untreated controls, epidermoid A431 cells were the most susceptible to
UT-ex with a residual cell viability of less than 10% at 10 mg/ml of UT-
ex (Fig. 1A).
Bright-ﬁeld microscopy and imaging conﬁrmed the major sensitivity
of A431 cells compared to the other cell lines. However, upon treatment
with 10 mg/ml of UT-ex, all tested cells exhibited a round morphology,
a cytoplasmic vacuolization and loss of cell-cell contacts, indicating
severe cell damage (Fig. 1B).
To better examine their diﬀerent susceptibility, we performed a
more detailed evaluation of UT-ex, cytotoxicity on squamous cancer
cell lines compared to spontaneously immortalized HaCaT keratino-
cytes. We conﬁrmed that A431 cells were the most sensitive to UT-ex
with a half-maximal inhibitory concentration (IC50) between 1.5 and
2.0 mg/ml at 48 h of treatment (Fig. 2A). HaCaT cell viability began to
progressively decline at UT-ex concentration of 1.5 mg/ml of UT-ex,
(Fig. 2B) while viability of SCC022, SCC011 and SCC013 cells dropped
precipitously to 20–30% upon treatment with 10 mg/ml of UT-ex for
48 h (Fig. 2C–E). As shown in Fig. 2A–E, the reduction of cell viability
was most pronounced at 48 and 72 h of treatment in all cell lines thus
revealing a time-dependent toxicity of UT-ex. Remarkably, at 10 mg/ml
of UT-ex, untransformed HaCaT keratinocytes were more resistant than
all squamous carcinoma cell lines tested (Fig. 2A–E). Similar results
were obtained by treating cells with the extract that was ﬁrst
lyophilized, stored at−20 °C for 1 month and then reconstituted by re-
adding water up to the initial volume (reUT-ex) (Fig. S1).
Using MTT assays, we detected an increase of cell viability at UT-ex
concentrations ranging between 0.3 and 1.5 mg/ml, in all tested cell
lines (Fig. 2A–E). With cell growth proﬁling, however, we found no
increase in the rate of cell proliferation (Fig. S2 A–C).
Next, we focused our further studies on A431 and SCC022 carci-
noma cells which are the most sensitive and the most resistant to UT-ex,
respectively.
We investigated the eﬀect of low doses of UT-ex (0.3 and 1.5 mg/
ml) on cell cycle distribution by ﬂow cytometry. As shown in Fig. 3A, B
and C, there was a signiﬁcant change in the cell number in the diﬀerent
cell cycle phases. Speciﬁcally, at 1.5 mg/ml of UT-ex, in HaCaT cells we
observed accumulation of G1 arrested cells (3 A) while the majority of
A431 and SCC022 cells were arrested in the G2/M phase (Fig. 3B and
C). The observed cell cycle arrest was associated with the induction of
the cell cycle inhibitor p21/WAF protein (Fig. 3D).
The presence of cleaved Poly [ADP-ribose] polymerase 1 (PARP-1)
is used diagnostically to detect apoptosis in many cell types (Gobeil
et al., 2001). Thus, we analyzed PARP-1 proteolysis by immunoblot in
HaCaT, A431 and SCC022 cells treated with 0.3, 3.0 and 10 mg/ml of
UT-ex. Based on the MTT assays, at this concentration range, we ex-
pected to detect molecular evidence of UT-ex eﬀects. In fact, at 0.3 mg/
ml of UT-ex all cell lines showed a viability comparable to the control
cells; at 3.0 mg/ml the most resistant cell line (SCC022) exhibited a
clear response to the treatment; ﬁnally at 10 mg/ml, all cell lines were
sensitive to UT-ex treatment and underwent cell death.
The appearance of the 89 kDa PARP-1 fragment generated by
Caspase 3 cleavage (Fig. 4A, black arrows) along with the apoptotic
DNA fragmentation pattern observed in UT-ex treated HaCaT cells
suggested the occurrence of apoptosis (Fig. 4B). This was also
Fig. 3. Cell cycle analysis of HaCaT (A), A431 (B) and SCC022 (C) cells treated or not with 0.3 and 1.5 mg/ml of UT-ex. Each plot represents the percentage of cells in the diﬀerent cell
cycle phases. (D) Immunoblot analysis of extracts from HaCaT, A431 and SCC022 cells treated with 0.3 and 1.5 mg/ml of UT-ex for 24 h. Aliquots of extracts (25 μg) were loaded and
subjected to SDS-PAGE and immunoblot analysis with p21-WAF and GAPDH antibodies.
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conﬁrmed by the comet assay (Fig. S3) and induction of the proa-
poptotic Bax protein in HaCaT and SCC022 cells (Fig. 4C). Un-
fortunately, because of their high sensitivity to UT-ex, very limited
amount of cell extract was recovered from A431 cells treated with
10 mg/ml of UT-ex. However, the strong induction of γ-H2AX histone
protein indicated the occurrence of DNA damage in all tested cell lines
(Fig. 4C).
3.2. UT-ex induces oxidative stress in HaCaT and A431 cells
Previous studies have shown that many natural products cause
apoptosis in cancer cells through the production of Reactive Oxygen
Species (ROS) (Martin-Cordero et al., 2012). Therefore, we tested
whether apoptosis induced by UT-ex was ROS-dependent using ﬂow
cytometry after staining with 2′−7′ dicloroﬂuorescin diacetate
(DCFDA). Control cells were incubated for 30 min with DCFDA alone,
while treated cells were incubated with UT-ex (0.3 or 3.0 mg/ml) for
24 h and subsequently with DCFDA for 30 min. The amount of ROS was
normalized for a sample of cells without DCFA. Compared to control
cells, HaCaT and A431 cells treated with 0.3 mg/ml of UT-ex showed a
moderate increase of intracellular ROS (Fig. 5). Treatment with 3 mg/
ml of UT-ex, instead, resulted in a 28% and 70% increase in ROS
production in HaCaT and A431 cells, respectively (Fig. 5). These results
strongly suggest that the observed cell death was ROS-dependent.
3.3. UT-ex inﬂuences YB-1 proteolytic cleavage
The multifunctional Y-box binding Protein-1 (YB-1 or YBX-1) pro-
vides cellular protection from oxidative stress and participates in DNA
damage repair mechanisms by interacting with Mre11 and Rad50
complexes (Somasekharan et al., 2015; Kim et al., 2013). It was pre-
viously reported that YB-1 cleavage by the 20 S proteasome leads to the
accumulation of a 36 kDa nuclear form which is recruited to DNA da-
mage sites to participate in DNA repair (Kim et al., 2013).
We tested the eﬀect of increasing the amount of UT-ex (from 0.3 to
10 mg/ml) on YB-1 using immunoblot analyses.
In untreated HaCaT cells, full length YB-1 (50 kDa) was largely
predominant over the 36 kDa form (Fig. 6A, lane 1). However, the
36 kDa proteolytic fragment of YB-1 increased as a result of UT-ex
treatment up to 3.0 mg/ml (Fig. 6A, lanes 2–5) and abruptly dis-
appeared at 10 mg/ml of UT-ex (Fig. 6A, lane 6 and 7). Interestingly, in
untreated SCC022 and A431 cells, the 50 and 36 kDa forms of YB-1
were almost equally represented in (Fig. 6B and C, lanes 1). However,
similarly to what we observed in HaCaT, in SCC022 cells the 36 kDa
Fig. 4. (A) Representative immunoblot analyses of HaCaT, A431 and SCC022 cells after 48 h of treatment with the indicated doses of UT-ex (mg/ml). Equal aliquots of extracts (25 μg)
were subjected to immunoblot analysis with PARP1 antibodies. (B) Electrophoresis on agarose gel (1.2%) of genomic DNA isolated from HaCaT cells treated or not with 10 mg/ml of UT-
ex extract. (C) upper panel Representative immunoblot analyses of HaCaT, A431 and SCC022 cells after 48 h of treatment with the indicated doses of UT-ex (mg/ml). Equal aliquots of
extracts (25 μg) were subjected to immunoblot analysis with Bax and H2AX antibodies. GAPDH antibodies were used as loading control; lower panel Densitometric analysis of Bax protein
levels.
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band of YB-1 was signiﬁcantly reduced at 10 mg/ml of UT-ex (Fig. 6B,
lane 4). In A431 cells, however, the 36 kDa YB-1 band disappeared in
cells treated with 3.0 mg/ml of UT-ex (Fig. 6C, lanes 3 and 5). In
contrast, the level of full length YB-1 appeared to be unaﬀected or even
increased thereby suggesting that full length YB-1 was stabilized
(Fig. 6A, B, C). However, it has to be noted that at 10 mg/ml of UT-ex
both YB-1 and GAPDH were undetectable because of extensive cell
death (Fig. 6C, lane 6). Strikingly, the level of hnRNPA1, a RNA-binding
protein that is known to be degraded by caspase 3 (Back et al., 2002),
was completely degraded in cells treated with UT-ex, in a dose-de-
pendent manner (Fig. 6D, E and F).
We have previously shown that YB-1 is polyubiquitinated (Di
Martino et al., 2016). Moreover, under DNA damage conditions, YB-1
undergoes a proteasome-dependent proteolytic cleavage, resulting in
the YB-1 36 kDa form. Accumulation of full length YB-1, with the
parallel disappearance of the YB-1 36 kDa, suggests an impairment of
proteasome activity. Therefore, we investigated whether UT-ex caused
an accumulation of protein ubiquitination. Immunoblot analysis of total
protein extract from untreated and UT-ex treated cells clearly showed
an increase of total ubi-conjugated proteins, thereby conﬁrming a de-
fective proteasomal degradation in the presence of UT-ex (Fig. 7A, B,
C). Finally, we performed a speciﬁc immunoprecipitation of YB-1 pro-
tein. YB-1 immunocomplexes were then analyzed by immunoblot with
Ubiquitin (Ubi) antibodies. As shown in Fig. 7D, the signal obtained
from cells treated with UT-ex was enhanced, thus conﬁrming that Ubi-
conjugated YB-1 was accumulated (Fig. 7D).
3.4. Preliminary chemical analysis of aqueous extract
The dried aqueous extract obtained from Uncaria tomentosa cell
cultures was analyzed by TLC in diﬀerent solvent mixtures: i-PrOH:H2O
8:2, v/v; CHCl3:i-PrOH 9:1, v/v; EtOAc:n-hexane 6:4, v/v that showed
the presence of a mixtures of low and medium molecular weight
compounds. The extract was dissolved in a minimal amount of ultra-
pure Milli-Q water and dialysed (cut-oﬀ 3500 Da). The tube content
(IN) and the out fraction (OUT) were collected lyophilized, and re-
suspended in the same initial volume. The fractions were separately
tested for their cytotoxic activity against A431 cells by MTT assay as
previously described. Remarkably, most of cytotoxic activity remained
in the OUT fraction that contains hydrophilic low molecular weight
metabolites (Fig. S4). Therefore, the OUT fraction was analyzed by
HPLC, 1H NMR and LC-TOF.
The HPLC proﬁle of the OUT fraction of the dialyses (Fig. S5)
showed the presence of several peaks. Its 1H NMR (Fig. S6) showed the
presence of two main anomeric protons at δ 5.4 and 5.1 ppm and
complex signals in the region of the hydroxylated protons in the range
of δ 4.1–3.2 ppm, suggesting the presence of saccharide mixtures.
Complex signals were also present in the region of aliphatic protons at δ
2.0–1.5 ppm (Pretsch et al., 2000).
The LC-MS/TOF (Figs. S7 and 8) spectra showed eight main peaks
detected in the molecular weight range of 350–570 m/z that could be
consistent with the nature of metabolites suggested by HPLC and 1H
NMR analysis. In particular, four of them (Fig. S7) showed both the
sodiated [M + Na]+ and the sodiated dimmer [2 M + Na]+ forms at
m/z 383 and 743, 409 and 795, 428 and 833, 501 and 979, consistent
with molecular weight of 360, 386, 405 and 478, respectively.
4. Discussion
Biological eﬀects of complex mixtures of phytochemicals are diﬃ-
cult to predict from chemical analysis of individual constituents be-
cause they generally combine the advantage of targeting multiple mo-
lecular pathways that are involved in complex disorders with a
considerable reduction in toxic side eﬀects (Wagner et al., 1985b).
Cancer control may beneﬁt from the potential in alternative thera-
pies. Ideally, a phytochemical should possess anti-tumor properties,
minimal, toxicity and a deﬁned mechanism of action. The knowledge of
the mechanism of action and the signaling pathways targeted by natural
compounds can lead to understanding the molecular mechanisms in-
volved in cancer progression and may indicate novel therapeutic ap-
proaches.
Induction of apoptosis is considered one of the most important
markers of cytotoxicity for antitumor agents. Some natural compounds,
including plant metabolites, are able to induce apoptotic pathways that,
through various mechanisms are usually blocked in cancer cells.
We have presented evidence that an aqueous extract from Uncaria
tomentosa barks aﬀects viability of squamous carcinoma cells through a
combination of increased oxidative stress and impaired DNA repair. Our
data are in agreement with previous studies showing that Uncaria to-
mentosa extract is able to enhance chemotherapy-induced apoptosis,
with an increase in caspase activities and DNA fragments in cultures of
neoplastic cells (De Oliveira et al., 2014).
In our study, Uncaria tomentosa water extract exhibited dose-de-
pendent cytotoxic and antimitotic eﬀects on human spontaneously
immortalized HaCaT keratinocytes and squamous carcinoma cells. The
inhibitory eﬀect on cell viability was time and dose-dependent.
Remarkably, compared to the other tumor cell lines used in this
study, the SCC022 cells exhibit a very diﬀerent response to UT-ex
treatment. However, in a previous work from our group (Troiano et al.,
Fig. 5. Percentage of intracellular ROS levels in HaCaT and A431 cells treated with 0.3 or
3.0 mg/ml UT-ex. Data were analyzed and converted in percentage of ROS by BD Accuri
C6 Software. Representative FACS-derived histograms showing increased ROS in HaCaT
(upper panel) and A431 (lower panel) cells treated with UT-ex 0.3 mg/ml (left panel) or
UT-ex 3.0 mg/ml (right panel) compared with control cells without DCFDA (% of ROS =
1) and untreated cells incubated with DCFDA. 20.000 events were evaluated. Data were
analyzed and converted in percentage of ROS by BD Accuri C6 Software.
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2015) we have shown that this cell line is PTEN-defective and therefore
exhibits constitutive AKTSer473 hyperphosphorylation that was even
potentiated by YB-1 silencing. Constitutive activation of AKT survival
pathway may be the likely explanation for the lower sensitivity of these
cells to UT-ex treatment.
Morphological changes induced by UT-ex were associated with
PARP1 cleavage, increase of BAX protein levels, and internucleosomal
DNA fragmentation indicating apoptosis.
An important ﬁnding of our work is that Uncaria-induced
cytotoxicity was associated with ROS production. ROS are also a by-
product of normal metabolism; short exposure of non-proliferating cells
to relatively low doses of ROS was shown to activate signal transduction
pathways comparable to the eﬀects of mitogens (Deavall et al., 2012).
This may be the most likely explanation for the increase of cell viability
observed at low concentrations of UT-ex, in the majority of the cell lines
tested in this work (HaCaT and SCCs). However, when the level of ROS
exceeded the cellular antioxidant capacity, their reactive nature may
otherwise cause damage to key cellular components and induce cell
Fig. 6. (A–C) Immunoblot analysis of HaCaT, SCC022 and A431 cells treated with 0.3, 3.0 and 10 mg/ml of UT-ex for 48 h. Equal aliquots of extracts (25 μg) were loaded and subjected to
SDS-PAGE and immunoblot analysis with YB-1 antibodies. GAPDH antibodies were used as loading control. (D-F) Immunoblot analysis of HaCaT, SCC022 and A431 cells treated with 0.3
and 3.0 and 10 mg/ml of UT-ex for 48 h. Equal aliquots of extracts (25 μg) were loaded and subjected to SDS-PAGE and immunoblot analysis with hnRNPA1 antibodies. Actinin
antibodies were used as loading control.
Fig. 7. (A–C) Immunoblot analysis of HaCaT, A431
and SCC022 cells treated with 0.3, 3.0 and 10 mg/ml
of UT-ex for 48 h. Equal aliquots of extracts (25 μg)
were loaded and subjected to SDS-PAGE and im-
munoblot analysis with Ubiquitin antibodies.
GAPDH antibodies were used as loading control. (D)
Equal aliquots of HaCaT cells treated with 0.3 and
3.0 and 10 mg/ml of UT-ex for 48 h shown in Fig. 7A
were immunoprecipitated (IP) with anti-YB-1 or an
irrelevant α-rabbit antibodies (IgG). Im-
munocomplexes were blotted and probed with Ubi-
quitin (left panel) or YB-1 (right panel) antibodies.
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death.
Because cancer cells are sensitive to oxidative stress, the mechanism
of action for many cancer chemotherapeutic drugs involves ROS-
mediated apoptosis (De Oliveira et al., 2014). Interestingly, after
treatment with low doses of UT-ex, immortalized keratinocytes were
still able to activate a G1/S cell cycle checkpoint, allowing them to
repair DNA damage before DNA duplication. This could potentially
explain their relative resistance to UT-ex induced apoptosis. Under the
same conditions, A431 and SCC022 cancer cells showed a defective G1/
S checkpoint with a consequent accumulation of G2/M arrested cells
followed by massive apoptosis.
Exposure of non-proliferating cells to relatively low doses of ROS
can activate mitogenic signals (Deavall et al., 2012). At low doses, UT-
ex increased HaCaT and A431 cell viability; however, we found no
signiﬁcant increase in the rate of cell proliferation, thereby suggesting
that, at the concentration tested, UT-ex could enhance cell metabolism
rather than cell proliferation.
Our in vitro studies implicate the Y-Box-binding protein 1 (YB-1) in
UT-ex induced apoptosis. YB-1 is a multifunctional protein participating
in oncogenesis and is an oncomarker of breast, lung, liver, ovarian and
squamous cell carcinoma (Lasham et al., 2013). We have previously
identiﬁed YB-1 as a partner of ΔNp63α, the predominant protein ex-
pressed in proliferative squamous epithelia, and demonstrated that YB-
1 and ΔNp63α interplay supports keratinocyte proliferation and pro-
tects keratinocytes from apoptosis under genotoxic stress (Di Martino
et al., 2016; Di Costanzo et al., 2012). YB-1 is predominantly localized
to cytoplasm, where it serves as a sensor of oxidative stress. Indeed, it
was found to be implicated in translational repression and assembly of
Stress Granules upon heat shock and oxidative stress (Kedersha et al.,
2005). However, in response to severe genotoxic insults, UV, doxor-
ubicin, cisplatin, etoposide and prolonged oxidative stress, YB-1 accu-
mulates into the nucleus and participates in DNA damage repair (Kim
et al., 2013). In particular, full length YB-1 (50 kDa) undergoes speciﬁc
post-translational modiﬁcations and limited cleavage by the protea-
some leading to the nuclear accumulation of the N-terminal YB-1
36 kDa fragment. YB-1 36 kDa form functionally interacts with BER
factors (NEIL1, PARP1 and 2) and Double Strand Break (DSB) repair
proteins MRE11 and Rad50 (Alemasova et al., 2016) and enhances cell
survival (Kim et al., 2013). We believe that the relevance of this me-
chanism in cancer-cell chemo-resistance is still underestimated.
Strikingly, we found that treatment of cells with lethal doses of UT-
ex were associated with the reduction/disappearance of the pro-sur-
vival YB-1 36 kDa form in HaCaT, SCC022 and A431 cells. Because the
level of full length YB-1 was unaﬀected, or even increased, by UT-ex
treatment, we postulate that UT-ex could have a proteasome-inhibitory
activity. The increase of total protein ubiquitination and the accumu-
lation of Ubiquitin-conjugated YB-1 conﬁrmed our hypothesis. It is not
hard to speculate that other proteasome inhibitors already in clinical
practice such as Bortezomib (Crawford et al., 2011) can exert their
anticancer eﬀects by targeting YB-1, and their relative eﬃcacy may
partly depend upon on their eﬀect on YB-1 proteolytic cleavage. Al-
though not exhaustive, chemical analysis of UT-ex showed that beside a
large amount of saccharides, it contained further low molecular weight
metabolites. Previously, phytochemical investigations on U. tomentosa
and related species suggested the presence of indole and oxindole al-
kaloids, triterpenes and polyphenols (Lock et al., 2016). However,
further puriﬁcation of the mixture is in progress in order to conﬁrm the
nature of these classes of compounds and identify those that are ef-
fective against squamous carcinoma cells.
5. Conclusion
Being at the interface between oxidative stress and molecular me-
chanisms controlling cell proliferation and DNA damage repair, the YB-
1 protein might not only provide a survival advantage to error-prone
cancer cells, but also protect them from chemotherapy-induced
apoptosis. We have clear evidence that Uncaria tomentosa water extracts
contains bioactive molecules that interfere with the proteasome-medi-
ated YB-1 proteolytic cleavage thus reducing the capacity of cells to
eﬀectively repair damaged DNA. Our study indicates that Uncaria
Tomentosa pro-apoptotic activity results from its ability to simulta-
neously induce oxidative DNA damage and antagonize the mechanisms
of DNA repair relying on the activity of YB-1 36 kDa form. In light of
our current knowledge about the pro-apoptotic eﬀects of UT-ex in
squamous cancer cells, we believe that this plant may have a high po-
tential value as an eﬀective agent for treatment of cancerous skin le-
sions.
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